Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $2,559 - $2,788
-51 Reduced 1.21%
4,150 $219,000
Q2 2023

Jul 24, 2023

SELL
$49.72 - $54.64 $9,794 - $10,764
-197 Reduced 4.48%
4,201 $227,000
Q1 2023

Apr 19, 2023

SELL
$45.09 - $50.03 $1,623 - $1,801
-36 Reduced 0.81%
4,398 $220,000
Q4 2022

Jan 30, 2023

BUY
$39.56 - $47.22 $175,409 - $209,373
4,434 New
4,434 $205,000
Q1 2022

May 11, 2022

SELL
$40.9 - $45.1 $20,327 - $22,414
-497 Closed
0 $0
Q4 2021

Mar 10, 2022

BUY
$38.07 - $44.87 $18,920 - $22,300
497 New
497 $22,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $141B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Comprehensive Financial Consultants Institutional, Inc. Portfolio

Follow Comprehensive Financial Consultants Institutional, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comprehensive Financial Consultants Institutional, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comprehensive Financial Consultants Institutional, Inc. with notifications on news.